Hardly any companies that had a SPAC debut during the boom have held on to high valuations. Many have filed for bankruptcy, shuttered or are worth a tiny fraction of their former highs. We take a look at some of them.
Health, Wellness & Biotech
Valuations for both public and private fitness companies have declined, investment is down, and fitness-related consumer spending remains tough to...
The week was slightly slower for huge rounds compared to previous ones, but half of the funding deals broke the $100 million mark.
Overall, biting bugs represent a big enough market to intrigue both startups and investors.
All in all, it was another strong week for big rounds. The top 10 list also includes three new unicorns.
For the second straight month, Menlo Park, California-based investing giant Andreessen Horowitz led the way among all investors, sealing 15 funding...
March seems to be picking up where February left off as far as investors being more willing to write big checks for even bigger rounds.
Some may have missed a few of the more unique startups that raised fresh cash in the year’s second month. With that, let’s take a look back and recap...
February was a big month for big rounds. Companies needed to raise $170 million or more just to make the tailend of our list of largest U.S. venture...
After two crazy weeks where we saw 18 raises of $100 million or more, this week saw a slight slowdown but was still relatively strong when it came to...
Using Crunchbase data, we identified a sample set of 28 private companies that have a peak valuation of $1 billion or more but haven’t raised a round...
67.1K Followers